Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties
Diffuse midline glioma (DMG) is a rare and aggressive pediatric brain tumor, with a median survival of less than 12 months. Due to its location in the pons, surgical resection is impossible, leaving radiation therapy as the only palliative treatment option. Unfortunately, radiation therapy yields minimal improvement in survival. Thus, characterization of the vascular component of the DMG microenvironment at the cellular and molecular levels following radiotherapy to improve therapeutic strategies. A human syngeneic blood-brain tumor barrier (BBTB) in vitro model, comprising endothelial cells, pericytes and DMG cells was submitted to a single dose of radiation (2 Gγ to 6 Gγ) and was characterized for its physical and metabolic properties over a period of 7 days post-exposure. The results were then compared to the effects of the same irradiation protocol on a physiologic blood-brain barrier (BBB) model. Following irradiation, the endothelial permeability of the BBB ECs and the BBTB ECs was preserved for up to 7 days but associated with Claudin-5 heterogeneous distribution at the ECs borders and decrease of expression after irradiation. Nevertheless, irradiation was found to potentiate the effect of TNFα on the physical integrity of the BBB, which was less important for the BBTB. The metabolic properties of the BBB and BBTB were modulated by radiation at the transcriptional level. Interestingly, different regulations were observed in endothelial cells and pericytes. Notably, pericytes have demonstrated compensatory effects. Immunoblots confirmed the decrease of BCRP, MRP4 and MFSD2A in BBTB endothelial cells after irradiation. Despite significant reduced efficiency, P-gp/BCRP efflux pump activity remains functional in endothelial cells and pericytes following irradiation. Irradiation sensitizes the BBB, but to a lesser extent the BBTB, to the effects of pro-inflammatory cytokines. The observed decrease in P-gp/BCRP activity, as well as the involvement of MFSD2A, MRP4 and Claudin-5 regulation, warrant further investigations.
Authors
- Mélanie Arcicasa
- Joanne Balsamelli
- Lucie Dehouck
- Marie‐Christine Boucau
- Fumitaka Shimizu (ORCID: https://orcid.org/0000-0003-4163-2939)
- M. Culot
- Caroline Mysiorek (ORCID: https://orcid.org/0000-0003-2338-8821)
- Emmanuel Sevin
- Ángel M. Carcaboso (ORCID: https://orcid.org/0000-0002-8485-426X)
- Samuel Meignan (ORCID: https://orcid.org/0000-0002-9386-7978)
- Marine Carroué
- Takashi Kanda (ORCID: https://orcid.org/0000-0001-8919-6377)
- Robert-Alain Toillon
- Eloise Happernegg
- Flavie Perrot
- Fabien Gosselet
Institutions
- Centre National de la Recherche Scientifique (FR)
- Hospital Sant Joan de Déu Barcelona (ES)
- Inserm (FR)
- Yamaguchi University (JP)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Institut pour la Recherche sur le Cancer de Lille (FR)
- Shimonoseki City Hospital (JP)
- Centre Oscar Lambret (FR)
- Université d'Artois (FR)
Publication Details
- Journal
- Fluids and Barriers of the CNS
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1186/s12987-026-00778-6
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fondation pour la Recherche Médicale